Literature DB >> 21350439

High prevalence of prolonged QT interval in obese hypogonadal males.

Francesca Pecori Giraldi1, Giuseppina Manzoni, Jorgo Michailidis, Massimo Scacchi, Marco Stramba-Badiale, Francesco Cavagnini.   

Abstract

Obese subjects show several electrocardiographic alterations, including prolonged QT interval, a marker for fatal cardiac arrhythmias. Prolonged QT interval has recently been linked to low testosterone levels, a frequent occurrence in male obese patients but no study has yet assessed whether hypoandrogenism contributes to QT interval prolongation in this population. Aim of this study was to evaluate whether prolonged QT interval is linked to hypogonadism in male obese subjects. QT interval corrected for heart rate (QTc) was measured from standard electrocardiogram recordings in 136 obese men (BMI 30 >kg/m(2), range 30.1-75.4 kg/m(2)). Obese men were classified as eugonadal or hypogonadal according to serum total testosterone levels (i.e., greater or less than 9.9 nmol/l). Our study showed that QTc measurements corrected by either Bazett (419 ± 3.2 vs. 408 ± 3.4 ms, P < 0.05), Fridericia (406.3 ± 3.39 vs. 396.4 ± 3.03 ms, P < 0.05) or Hodges (407.0 ± 3.12 vs. 397.3 ± 2.84 ms, P < 0.05) were longer in hypogonadal compared with eugonadal obese men; further, prolonged QTc interval (i.e., >440 ms) was more frequent among hypogonadal compared with eugonadal obese men (23% vs. 10%, P < 0.05). The degree of weight excess, diabetes, sleep apnoea and potassium levels were not associated with prolonged QTc. In conclusion, obese hypogonadal men show a greater prevalence of prolonged QT interval compared with their eugonadal counterparts. It appears therefore that low levels of testosterone in obese men may contribute to the arrhythmogenic profile of these patients, a heretofore unknown link which warrants further clinical attention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350439     DOI: 10.1038/oby.2011.33

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

Review 1.  Testosterone, myocardial function, and mortality.

Authors:  Vittorio Emanuele Bianchi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

2.  Wasting syndrome with deep bradycardia as presenting manifestation of long-standing severe male hypogonadotropic hypogonadism: a case series.

Authors:  Elena Passeri; Marco Bonomi; Francesco Dangelo; Luca Persani; Sabrina Corbetta
Journal:  BMC Endocr Disord       Date:  2014-09-27       Impact factor: 2.763

Review 3.  Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.

Authors:  T Hugh Jones; Daniel M Kelly
Journal:  Asian J Androl       Date:  2018 Mar-Apr       Impact factor: 3.285

4.  Changes in left ventricular repolarization after short-term testosterone replacement therapy in hypogonadal males.

Authors:  G Piccirillo; F Moscucci; R Pofi; G D'Alessandro; M Minnetti; A M Isidori; D Francomano; A Lenzi; P E Puddu; J Alexandre; D Magrì; A Aversa
Journal:  J Endocrinol Invest       Date:  2019-03-05       Impact factor: 4.256

5.  Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.

Authors:  Christian Trolle; Kristian H Mortensen; Lisbeth N Pedersen; Agnethe Berglund; Henrik K Jensen; Niels H Andersen; Claus H Gravholt
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

Review 6.  Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

Authors:  Peyman Mesbah Oskui; William J French; Michael J Herring; Guy S Mayeda; Steven Burstein; Robert A Kloner
Journal:  J Am Heart Assoc       Date:  2013-11-15       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.